Label: POLYETHYLENE GLYCOL- 3350 powder, for solution

  • NDC Code(s): 51079-306-01, 51079-306-30
  • Packager: Mylan Institutional Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated July 16, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each dose)

    Polyethylene Glycol 3350, USP, 17 g

  • Purpose

    Osmotic Laxative

  • Use

    • relieves occasional constipation (irregularity)
    • generally produces a bowel movement in 1 to 3 days
  • Warnings

    Allergy alert:Do not use if you are allergic to polyethylene glycol

  • Do not use

    if you have kidney disease, except under the advice and supervision of a doctor

  • Ask a doctor before use if you have

    • nausea, vomiting or abdominal pain
    • a sudden change in bowel habits that lasts over 2 weeks
    • irritable bowel syndrome
  • Ask a doctor or pharmacist before use if you are

    taking a prescription drug

  • When using this product

    you may have loose, watery, more frequent stools

  • Stop use and ask a doctor if

    • you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. These may be signs of a serious condition.
    • you get diarrhea
    • you need to use a laxative for longer than 1 week
  • If pregnant or breast-feeding,

    ask a health professional before use.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • do not take more than directed unless advised by your doctor
    • adults and children 17 years of age and older:
      • use once a day
      • stir and dissolve the contents of one pouch (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
      • do not combine with starch-based thickeners used for difficulty swallowing
      • ensure that the powder is fully dissolved before drinking
      • do no drink if there are any clumps
      • do not use more than 7 days
    • children 16 years of age or under: ask a doctor
  • Other Information

    • store at 20° to 25°C (68° to 77°F)
    • tamper-evident: do not use if pouch is damaged or torn
    • for institutional use only
  • Inactive ingredients

    none

  • Questions or comments?

    1-877-4-INFO-RX (1-877-446-3679)

    Manufactured for:
    Mylan Institutional Inc.
    Rockford, IL 61103 U.S.A.

    MII306-30:R8

  • Principal Display Panel

    NDC 51079-306-30

    Polyethylene Glycol 3350, USP
    Powder for Solution,
    Osmotic Laxative

    • Relieves Occasional Constipation/Irregularity
    • Softens Stool

     

    • Unflavored
    • Powder
    • Grit Free
    • Sugar Free
    • Dissolves in Any Beverage

    This carton contains 30 single-dose pouches.
    Each pouch contains 17 grams of
    polyethylene glycol 3350, USP powder.

    For institutional use only.     30 Single-Dose Pouches

    Polyethylene Glycol 3350 Carton Label
  • INGREDIENTS AND APPEARANCE
    POLYETHYLENE GLYCOL (3350) 
    polyethylene glycol (3350) powder, for solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51079-306
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    POLYETHYLENE GLYCOL 3500 (UNII: FVS1AZD90Y) (POLYETHYLENE GLYCOL 3500 - UNII:FVS1AZD90Y) POLYETHYLENE GLYCOL 350017 g  in 17 g
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:51079-306-3030 in 1 CARTON10/12/2009
    1NDC:51079-306-0117 g in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07891510/12/2009
    Labeler - Mylan Institutional Inc. (039615992)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!